SLI
2.116,16
PKT
-15,47
PKT
-0,73
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
31.01.08 | UBS reduzieren | Independent Research GmbH | |
01.02.08 | Straumann overweight | JP Morgan Chase & Co. | |
29.01.08 | Geberit halten | Öko Invest | |
29.01.08 | Swisscom neutral | JP Morgan Chase & Co. | |
25.01.08 | Zurich Insurance buy | Société Générale Group (SG) | |
25.01.08 | Richemont overweight | JP Morgan Chase & Co. | |
24.01.08 | Richemont overweight | JP Morgan Chase & Co. | |
22.01.08 | Lindt buy | Société Générale Group (SG) | |
21.01.08 | Swatch (I) sell | Société Générale Group (SG) | |
21.01.08 | Novartis halten | Euro am Sonntag | |
21.01.08 | Swatch (I) neutral | JP Morgan Chase & Co. | |
21.01.08 | Novartis overweight | JP Morgan Chase & Co. | |
18.01.08 | Lindt buy | Société Générale Group (SG) | |
17.01.08 | Novartis hold | Citigroup Corp. | |
17.01.08 | Nestlé | Focus Money | |
18.01.08 | Novartis add | WestLB AG | |
21.01.08 | Novartis accumulate | Jyske Bank Group | |
17.01.08 | Novartis underperform | Credit Suisse Group | |
14.01.08 | Swiss Life | AC Research | |
16.01.08 | Novartis accumulate | Jyske Bank Group | |
14.01.08 | UBS reduzieren | Independent Research GmbH | |
14.01.08 | UBS kaufen | Die Actien-Börse | |
14.01.08 | UBS kaufen | Die Actien-Börse | |
14.01.08 | Adecco SA | Euro am Sonntag | |
11.01.08 | Novartis overweight | JP Morgan Chase & Co. | |
11.01.08 | Swiss Life hold | SRC Research | |
10.01.08 | Holcim | Focus Money | |
09.01.08 | Holcim neutral | JP Morgan Chase & Co. | |
03.01.08 | Richemont kaufen | Minerva Investments | |
03.01.08 | Holcim | Focus Money | |
27.12.07 | Holcim kaufen | Wertpapier | |
20.12.07 | Novartis halten | Der Aktionär | |
20.12.07 | UBS neutral | Goldman Sachs Group Inc. | |
18.12.07 | Nestlé neutral | UBS AG | |
17.12.07 | Swiss Life neutral | JP Morgan Chase & Co. | |
17.12.07 | UBS | Euro am Sonntag | |
14.12.07 | UBS buy | SEB AG | |
17.12.07 | Novartis equal-weight | Morgan Stanley | |
13.12.07 | Swiss Life neutral | UBS AG | |
14.12.07 | Novartis add | WestLB AG |